血管内動脈瘤修復術の世界市場-2022-2029年

市場力学

腹部大動脈瘤の血管内治療における革新的な技術が、市場の成長を牽引すると予想されます。

ポリマーベースの技術は、血管内アプローチでAAAを治療するために提案されています。2つの異なるポリマーベースのプラットフォームが臨床目的で開発されています。動脈瘤の円周方向の封鎖を行うポリマーデバイスは、安全性と有効性が証明されています。さらに、Oリングを大動脈壁に適合させることにより、このポリマーベースのプラットフォームは動脈瘤のカスタマイズされたシーリングを提供し、頸部の拡張に影響を与えることなく長年にわたって安定した状態を維持することができます。従来の金属製ステントフレームで布を支えるのではなく、ポリマー製チャネルを用いたこのようなプラットフォームの薄型化は、低侵襲なEVAR治療への患者の適用を拡大する可能性があります。この種の技術のインパクトはすでに大きいです。したがって、ポリマーの特性を利用して動脈瘤をカスタマイズして封鎖する可能性は、EVAR手術における大きな革命となっています。したがって、上記の記述から予測期間において市場が牽引されることが予想されます。

制約

ステント瞬間動脈瘤とうっ血性心不全のリスク、不十分な償還政策、およびオープン手術と比較してEVAR手順の膨張コストにつながります。これらは、予測期間中に市場が阻害されると予想される要因の一部です。

COVID-19の影響分析

COVID-19の大流行は、ヘルスケアシステムと市場に中程度の影響を及ぼしました。パンデミックは、腹部大動脈瘤（AAA）の修復を含む心血管処置の実施件数の大幅な減少を含んでいます。例えば、COVID-19の感染に関する懸念から、英国のほとんどの地域でAAAスクリーニング（サーベイランスを含む）がロックダウン中に一時停止され、（NHS内の能力低下の結果）外科的介入の遅れによるリスクの軽減に関して戦略が検討されています。さらに、破裂したAAAは死亡率が高く、AAA検診を受ける必要があります。年間約30万人の男性がスクリーニング検査を受け、そのうち約1％がAAAであることが判明していますが、約15,000人の男性がまだ検査を受けていないのが現状です。このため、予測期間中に市場は活性化すると考えられます。

産業分析

血管内動脈瘤修復術市場は、アンメットニーズ、価格分析、サプライチェーン分析、規制分析など、様々な産業要因に基づく市場の詳細な分析を提供します。

世界の血管内動脈瘤修復術市場レポートでは、約45+市場データ表、40+図、180ページの構成で提供しています。

目次

第1章 調査手法と調査範囲

• 調査手法
• 調査目的および調査範囲

第2章 市場の定義と概要

第3章 エグゼクティブサマリー

• 製品タイプ別市場内訳
• 適応症別市場内訳
• 年齢別市場内訳
• エンドユーザー別市場内訳
• 地域別市場内訳

第4章 市場力学

• 市場影響要因
  • 促進要因
    • 腹部大動脈瘤の血管内治療における革新的な技術が、市場成長を促進すると予想されます。
  • 抑制要因
    • 開腹手術に比べ、EVAR手術の費用が高騰していることが市場成長の阻害要因になると予想されます。
  • 市場参入の機会
  • 影響分析

第5章 産業分析

• ポーターのファイブフォース分析
• 規制分析
• 保険償還分析
• アンメットニーズ分析

第6章 COVID-19分析

• COVID-19の市場分析
  • COVID-19以前の市場シナリオ
  • COVID-19の現在の市場シナリオ
  • COVID-19の後、あるいは将来のシナリオ
• COVID-19の中での価格ダイナミクス
• 需要-供給スペクトラム
• パンデミック時の市場に関連する政府の取り組み
• メーカーの戦略的な取り組み
• まとめ

第7章 製品タイプ別

• フェネストレート型EVAR
• 補助的なステントグラフト
• 分岐型ステントグラフト
• その他

第8章 適応症別

• 腹部大動脈瘤（AAA）
• 胸部大動脈瘤（TAA）
• 胸腹部大動脈瘤（TAAA）
• その他

第9章 年齢別

• 小児
• 成人
• 老年

第10章 エンドユーザー別

• 病院
• 外来手術センター
• クリニック
• その他

第11章 地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • その他欧州
• 南米
  • ブラジル
  • アルゼンチン
  • その他の南米地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • オーストラリア
  • その他アジア太平洋地域
• 中東・アフリカ地域

第12章 競合情勢

• 主な展開と戦略
• 企業シェア分析
• 製品ベンチマーク
• 注目の主要企業リスト

第13章 企業プロファイル

• Cardinal Health
  • 企業概要
  • 製品ポートフォリオと説明
  • 主なハイライト
  • 財務概要
• Lombard Medical Limited
• Endologix Inc.
• Terumo Corporation
• MicroPort Scientific Corporation
• JOTEC GmbH
• W. L. Gore & Associates, Inc.
• Cook Group Incorporated
• Medtronic plc（*LIST NOT EXHAUSTIVE*）

第14章 DataM

Market Overview

Endovascular Aneurysm Repair market size was valued US$ YY million in 2021 and is estimated to reach US$ YY million by 2029, growing at a CAGR of 4.6% during the forecast period (2022-2029).

An aortic aneurysm is a condition in which the aorta becomes enlarged. Abdominal pain, low blood pressure, loss of consciousness, and even death can result from these diseases. Endovascular aneurysm repair (EVAR) is a minimally invasive surgical procedure that can treat abdominal and thoracic aortic aneurysms. It is a less invasive and less time-consuming alternative to open surgery for abdominal aortic aneurysms (AAA).

Market Dynamics

Innovative technologies in the endovascular treatment of abdominal aortic aneurysms are expected to drive market growth.

Polymer-based technology has been proposed for treating AAA with an endovascular approach. Two different polymer-based platforms have been developed for clinical purposes. The polymer device to create a circumferential sealing of the aneurysm has proven safe and effective. Moreover, adapting the O-ring to the aortic wall, this polymer-based platform offers a customized sealing of the aneurysm, which remains stable over the years without influencing neck dilatation. The low profile of such a platform based on polymer channels rather than traditional metallic stent frames to support the fabric may expand patient applicability for a minimally invasive EVAR treatment. The impact of this kind of technology is already significant. Therefore, the possibility of using polymer characteristics to create a customized sealing of the aneurysm has been a great revolution in EVAR procedures. Thus, the market is expected to drive in the forecast period from the above statements.

Restraint:

The stent moment leads to the risk of an aneurysm and congestive heart failure, insufficient reimbursement policies, and the inflated cost of EVAR procedures compared to open surgeries. These are some of the factors that the market is expected to get hampered in the forecast period.

COVID-19 Impact Analysis

The COVID-19 pandemic has moderately impacted healthcare systems and the market. The pandemic included a substantial reduction in the number of cardiovascular procedures performed, including repair of Abdominal Aortic Aneurysms (AAA). For instance, AAA screening (including surveillance) in most areas of the UK was paused during the lockdown due to concerns about COVID-19 transmission and while strategies are considered regarding mitigating risk from delayed surgical intervention (as a result of reduced capacity within the NHS). Moreover, ruptured AAA carries a high mortality and screening for AAA. Circa 300,000 men are offered screening annually, of whom around 1% are found to have an AAA, while approximately 15,000 men are yet to tests. Thus, the market will undergo impetus during the forecast period.

Industry Analysis

The endovascular aneurysm repair market provides in-depth analysis of the market based on various industry factors such as unmet needs, pricing analysis, supply chain analysis, regulatory analysis etc.

Segment Analysis

The adjunctive stent graft segment is expected to hold the largest market share in the endovascular aneurysm repair market.

The adjunctive stent-graft segment accounted for the largest market share in 2021. Adjunctive stenting significantly reduces the risk of postoperative stent-graft limb occlusion without obvious compromise to the aneurysm repair. Endovascular grafting is a minimally invasive method to treat an aortic aneurysm. Through minor incisions in the groin, a stent graft (a fabric tube supported by metal wire stents that support the weak area in the aorta) is placed into the aneurysm. Endovascular aneurysm treatment does not require a major incision and has a significantly quicker recovery than traditional open surgery. Therefore, it increased the demand for adjunctive stent graft, due to which the market is expected to hold the largest market share in the forecast period.

Geographical Analysis

North American region is expected to hold the largest market share in the global endovascular aneurysm repair market.

North America accounted for the highest revenue share in 2021. The increasing prevalence of aneurysms and the rising geriatric population are more prone to this condition, due to which the market is expected to boost in the forecast period. For instance, Aortic aneurysms have an incidence of 5-10 cases per 100,000 in the United States and are more common in men over 60. Though aortic aneurysms do not directly cause death, complications arising from an aneurysm - such as dissection or rupture - cause approximately 15,000 deaths annually. AA primarily affects elderly males in the sixth and seventh decades of life with tobacco use, hypertension and atherosclerosis risk factors. For AAA, individuals with first-degree family members with the disease are at two-fold risk of developing AAA compared to patients with no family history. Moreover, according to the Population Reference Bureau report, the number of Americans aged 65 and up is expected to double by 2060, from 46 million to nearly 98 million. Therefore, it increases the demand for AAA treatments such as EVAR, due to which the North American region is expected to hold the largest market share in the forecast period.

Competitive Landscape

Major key players in the endovascular aneurysm repair market are Cardinal Health, Lombard Medical Limited, Endologix Inc., Terumo Corporation, MicroPort Scientific Corporation, JOTEC GmbH, W. L. Gore & Associates, Inc., Cook Group Incorporated and Medtronic plc.

Medtronic plc:

Overview:

Medtronic plc is an American-Irish registered medical device company primarily operating in the United States. It has an operational and executive headquarters in Fridley, Minnesota, in the US. Moreover, it develops and manufactures devices and therapies to treat more than 30 chronic diseases, including heart failure, Parkinson's disease, urinary incontinence, Down syndrome, obesity, chronic pain, spinal disorders and diabetes. It is operated in 140 countries and employs over 104,950 people.

Product Portfolio:

Heli-FX EndoAnchor system: The Heli-FX EndoAnchor system is intended to provide fixation and sealing between endovascular aortic grafts and the native artery.

The global endovascular aneurysm repair market report would provide an access to an approx. 45+market data table, 40+figures and 180pages.

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

• 3.1. Market Snippet by Product Type
• 3.2. Market Snippet by Indication
• 3.3. Market Snippet by Age
• 3.4. Market Snippet by End user
• 3.5. Market Snippet by Region

4. Market Dynamics

• 4.1. Market Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. Innovative technologies in the endovascular treatment of abdominal aortic aneurysms are expected to drive market growth.
  • 4.1.2. Restraints:
    • 4.1.2.1. The inflated cost of EVAR procedures compared to open surgeries is expected to hamper the market growth.
  • 4.1.3. Opportunity
  • 4.1.4. Impact Analysis

5. Industry Analysis

• 5.1. Porter's Five Forces Analysis
• 5.2. Regulatory Analysis
• 5.3. Reimbursement Analysis
• 5.4. Unmet Needs

6. COVID-19 Analysis

• 6.1. Analysis of Covid-19 on the Market
  • 6.1.1. Before COVID-19 Market Scenario
  • 6.1.2. Present COVID-19 Market Scenario
  • 6.1.3. After COVID-19 or Future Scenario
• 6.2. Pricing Dynamics Amid Covid-19
• 6.3. Demand-Supply Spectrum
• 6.4. Government Initiatives Related to the Market During Pandemic
• 6.5. Manufacturers Strategic Initiatives
• 6.6. Conclusion

7. By Product Type

• 7.1. Introduction
  • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
  • 7.1.2. Market Attractiveness Index, By Product Type Segment
• 7.2. Fenestrated EVAR*
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
• 7.3. Adjunctive Stent Graft
• 7.4. Branched Stent Graft
• 7.5. Others

8. By Indication

• 8.1. Introduction
  • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
  • 8.1.2. Market Attractiveness Index, By Indication Segment
• 8.2. Abdominal Aortic Aneurysm (AAA)*
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
• 8.3. Thoracic Aortic Aneurysm (TAA)
• 8.4. Thoracoabdominal Aortic Aneurysm (TAAA)
• 8.5. Others

9. By Age

• 9.1. Introduction
  • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Age
  • 9.1.2. Market Attractiveness Index, By Age Segment
• 9.2. Pediatric*
  • 9.2.1. Introduction
  • 9.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
• 9.3. Adult
• 9.4. Geriatric

10. By End user

• 10.1. Introduction
  • 10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
  • 10.1.2. Market Attractiveness Index, By End user Segment
• 10.2. Hospital*
  • 10.2.1. Introduction
  • 10.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
• 10.3. Ambulatory Surgery Centers
• 10.4. Clinics
• 10.5. Others

11. By Region

• 11.1. Introduction
  • 11.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
  • 11.1.2. Market Attractiveness Index, By Region
• 11.2. North America
  • 11.2.1. Introduction
  • 11.2.2. Key Region-Specific Dynamics
  • 11.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
  • 11.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
  • 11.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Age
  • 11.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
  • 11.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 11.2.7.1. U.S.
    • 11.2.7.2. Canada
    • 11.2.7.3. Mexico
• 11.3. Europe
  • 11.3.1. Introduction
  • 11.3.2. Key Region-Specific Dynamics
  • 11.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
  • 11.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
  • 11.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Age
  • 11.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
  • 11.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 11.3.7.1. Germany
    • 11.3.7.2. U.K.
    • 11.3.7.3. France
    • 11.3.7.4. Italy
    • 11.3.7.5. Spain
    • 11.3.7.6. Rest of Europe
• 11.4. South America
  • 11.4.1. Introduction
  • 11.4.2. Key Region-Specific Dynamics
  • 11.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
  • 11.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
  • 11.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Age
  • 11.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
  • 11.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 11.4.7.1. Brazil
    • 11.4.7.2. Argentina
    • 11.4.7.3. Rest of South America
• 11.5. Asia Pacific
  • 11.5.1. Introduction
  • 11.5.2. Key Region-Specific Dynamics
  • 11.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
  • 11.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
  • 11.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Age
  • 11.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
  • 11.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 11.5.7.1. China
    • 11.5.7.2. India
    • 11.5.7.3. Japan
    • 11.5.7.4. Australia
    • 11.5.7.5. Rest of Asia Pacific
• 11.6. Middle East and Africa
  • 11.6.1. Introduction
  • 11.6.2. Key Region-Specific Dynamics
  • 11.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
  • 11.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
  • 11.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Age
  • 11.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user

12. Competitive Landscape

• 12.1. Key Developments and Strategies
• 12.2. Company Share Analysis
• 12.3. Product Benchmarking
• 12.4. List of Key Companies to Watch

13. Company Profiles

• 13.1. Cardinal Health*
  • 13.1.1. Company Overview
  • 13.1.2. Product Portfolio and Description
  • 13.1.3. Key Highlights
  • 13.1.4. Financial Overview
• 13.2. Lombard Medical Limited
• 13.3. Endologix Inc.
• 13.4. Terumo Corporation
• 13.5. MicroPort Scientific Corporation
• 13.6. JOTEC GmbH
• 13.7. W. L. Gore & Associates, Inc.
• 13.8. Cook Group Incorporated
• 13.9. Medtronic plc (*LIST NOT EXHAUSTIVE*)

14. DataM Intelligence

• 14.1. Appendix
• 14.2. About Us
• 14.3. Contact Us